Rocket Pharmaceuticals (RCKT) Short Interest Ratio & Short Volume $3.34 +0.02 (+0.45%) As of 03:17 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Rocket Pharmaceuticals Short Interest DataRocket Pharmaceuticals (RCKT) has a short interest of 11.23 million shares, representing 13.83% of the float (the number of shares available for trading by the public). This marks a -12.95% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.3, indicating that it would take 2.3 days of the average trading volume of 3.72 million shares to cover all short positions.Current Short Interest11,230,000 sharesPrevious Short Interest12,900,000 sharesChange Vs. Previous Month-12.95%Dollar Volume Sold Short$34.25 millionShort Interest Ratio2.3 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares107,904,000 sharesShort Percent of Float13.83%Today's Trading Volume3,503,443 sharesAverage Trading Volume3,724,764 sharesToday's Volume Vs. Average94% Short Selling Rocket Pharmaceuticals? Sign up to receive the latest short interest report for Rocket Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRCKT Short Interest Over TimeRCKT Days to Cover Over TimeRCKT Percentage of Float Shorted Over Time Rocket Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/202511,230,000 shares $34.25 million -13.0%13.8%2.3 $3.05 7/15/202512,900,000 shares $36.25 million -5.0%N/A2.6 $2.81 6/30/202513,580,000 shares $33.27 million -3.3%16.9%2.7 $2.45 6/15/202514,040,000 shares $41.14 million +11.0%17.5%2.8 $2.93 5/31/202512,650,000 shares $31.37 million -9.3%19.4%2.7 $2.48 5/15/202513,940,000 shares $93.68 million +13.7%21.4%3.8 $6.72 4/30/202512,260,000 shares $93.54 million -7.8%N/A4.9 $7.63 4/15/202513,300,000 shares $86.85 million +6.9%20.4%5.8 $6.53 3/31/202512,440,000 shares $82.97 million +12.6%19.1%6.3 $6.67 3/15/202511,050,000 shares $96.80 million +0.1%17.0%7.2 $8.76 Get the Latest News and Ratings for RCKT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rocket Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/28/202511,040,000 shares $104.33 million -1.8%16.9%7.3 $9.45 2/15/202511,240,000 shares $117.68 million +6.8%17.2%7.8 $10.47 1/31/202510,520,000 shares $112.98 million -10.1%N/A7.4 $10.74 1/15/202511,700,000 shares $127.30 million -9.5%N/A9 $10.88 12/31/202412,930,000 shares $162.53 million +15.7%N/A11.3 $12.57 12/15/202411,180,000 shares $134.38 million +7.6%N/A10.4 $12.02 11/30/202410,390,000 shares $149.51 million -6.3%N/A11.2 $14.39 11/15/202411,090,000 shares $155.04 million -6.8%N/A12.1 $13.98 10/31/202411,900,000 shares $198.14 million +3.3%N/A14.3 $16.65 10/15/202411,520,000 shares $192.15 million +1.1%N/A13.5 $16.68 9/30/202411,400,000 shares $210.56 million +1.2%N/A13.1 $18.47 9/15/202411,260,000 shares $221.26 million +3.0%N/A13 $19.65 8/31/202410,930,000 shares $206.03 million +0.1%N/A13.1 $18.85 8/15/202410,920,000 shares $203.11 million +3.7%N/A13 $18.60 7/31/202410,530,000 shares $254.83 million +9.2%N/A13 $24.20 7/15/20249,640,000 shares $217.38 million +14.6%N/A12.1 $22.55 6/30/20248,410,000 shares $181.07 million -9.2%N/A10.7 $21.53 6/15/20249,260,000 shares $202.42 million -1.6%N/A13.1 $21.86 5/31/20249,410,000 shares $200.62 million -5.8%N/A14.2 $21.32 5/15/20249,990,000 shares $236.36 million +1.5%N/A14.6 $23.66 4/30/20249,840,000 shares $211.76 million -10.6%N/A13.5 $21.52 4/15/202411,000,000 shares $264.11 million +4.6%N/A15.3 $24.01 3/31/202410,520,000 shares $283.41 million +2.7%N/A14.7 $26.94 3/15/202410,240,000 shares $274.53 million +2.8%N/A13.6 $26.81 2/29/20249,960,000 shares $291.83 million +8.3%N/A12 $29.30 2/15/20249,200,000 shares $280.78 million +8.9%N/A11.3 $30.52 1/31/20248,450,000 shares $242.77 million +2.4%N/A10.4 $28.73 1/15/20248,250,000 shares $236.03 million -4.2%N/A9.3 $28.61 12/31/20238,610,000 shares $258.04 million -6.5%N/A9.7 $29.97 12/15/20239,210,000 shares $260.74 million +0.9%N/A10 $28.31“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad)Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. 11/30/20239,130,000 shares $213.00 million +0.4%N/A6.7 $23.33 11/15/20239,090,000 shares $198.53 million +0.4%N/A7 $21.84 10/31/20239,050,000 shares $163.81 million +0.7%N/A7.2 $18.10 10/15/20238,990,000 shares $157.77 million -6.5%N/A7.6 $17.55 9/30/20239,610,000 shares $196.91 million +6.7%N/A8.3 $20.49 9/15/20239,010,000 shares $211.28 million +24.5%N/A8.2 $23.45 8/31/20237,240,000 shares $113.31 million -6.2%N/A12 $15.65 8/15/20237,720,000 shares $125.37 million -1.0%N/A11.9 $16.24 7/31/20237,800,000 shares $140.79 million -2.1%N/A11.6 $18.05 7/15/20237,970,000 shares $157.17 million -2.9%N/A11.6 $19.72 6/30/20238,210,000 shares $163.13 million -1.9%N/A11.8 $19.87 6/15/20238,370,000 shares $190.42 million +6.0%N/A10.9 $22.75 5/31/20237,900,000 shares $165.35 million -2.5%N/A9.7 $20.93 5/15/20238,100,000 shares $176.34 million +0.9%N/A9.8 $21.77 4/30/20238,030,000 shares $143.90 million -2.3%N/A9.6 $17.92 4/15/20238,220,000 shares $146.64 million -9.3%N/A9.7 $17.84 3/31/20239,060,000 shares $155.20 million +1.5%N/A10.5 $17.13 3/15/20238,930,000 shares $160.83 million +7.5%N/A9.5 $18.01 2/28/20238,310,000 shares $159.64 million +9.9%N/A9.2 $19.21 2/15/20237,560,000 shares $148.33 million +11.0%N/A8.6 $19.62 1/31/20236,810,000 shares $147.98 million -8.1%N/A7.5 $21.73 1/15/20237,410,000 shares $165.76 million +5.3%N/A8.1 $22.37 12/30/20227,040,000 shares $137.77 million +0.1%N/A7.7 $19.57 12/15/20227,030,000 shares $154.80 million -7.9%N/A6.8 $22.02 11/30/20227,630,000 shares $144.05 million -2.3%N/A7.6 $18.88 11/15/20227,810,000 shares $161.67 million -16.9%N/A7.8 $20.70 10/31/20229,400,000 shares $175.40 million -0.5%N/A9.7 $18.66 10/15/20229,450,000 shares $154.41 million -16.4%15.5%9.7 $16.34 9/30/202211,300,000 shares $180.35 million -3.9%18.5%11.7 $15.96 9/15/202211,760,000 shares $183.22 million +8.3%19.2%13.5 $15.58 8/31/202210,860,000 shares $167.35 million +1.1%17.8%14.2 $15.41 8/15/202210,740,000 shares $196.76 million +18.9%17.6%13.1 $18.32 7/31/20229,030,000 shares $130.94 million +5.2%14.8%9.8 $14.50 7/15/20228,580,000 shares $138.31 million +4.0%14.1%9.7 $16.12 6/30/20228,250,000 shares $113.52 million +4.2%13.6%9.7 $13.76 6/15/20227,920,000 shares $86.96 million -4.6%13.0%10.2 $10.98 5/31/20228,300,000 shares $98.36 million +10.1%13.7%12 $11.85 5/15/20227,540,000 shares $68.54 million -0.3%12.4%12.9 $9.09 4/30/20227,560,000 shares $77.72 million -12.6%12.6%15.2 $10.28 4/15/20228,650,000 shares $117.29 million -1.3%14.5%18.3 $13.56 3/31/20228,760,000 shares $138.93 million +3.8%14.7%19.2 $15.86 3/15/20228,440,000 shares $116.30 million +2.1%14.1%15.7 $13.78 2/28/20228,270,000 shares $147.29 million +1.2%14.0%15.2 $17.81 2/15/20228,170,000 shares $163.40 million +4.6%13.8%15.2 $20.00 1/31/20227,810,000 shares $129.96 million -9.2%13.8%14.5 $16.64 1/15/20228,600,000 shares $161.42 million +9.3%14.1%17 $18.77 12/31/20217,870,000 shares $171.80 million -2.6%12.9%16.9 $21.83 12/15/20218,080,000 shares $186.73 million +4.5%13.2%20.6 $23.11 11/30/20217,730,000 shares $188.84 million +0.7%12.6%22.2 $24.43 11/15/20217,680,000 shares $198.91 million -2.5%12.5%20.8 $25.90“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad)Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. 10/29/20217,880,000 shares $234.11 million +0.9%12.8%20 $29.71 10/15/20217,810,000 shares $218.06 million -3.6%12.7%18.4 $27.92 9/30/20218,100,000 shares $242.11 million +2.4%13.1%17.6 $29.89 9/15/20217,910,000 shares $269.34 million +0.1%12.8%16.9 $34.05 8/31/20217,900,000 shares $270.26 million +2.3%12.8%17.2 $34.21 8/13/20217,720,000 shares $230.98 million -3.7%12.7%18.7 $29.92 7/30/20218,020,000 shares $287.28 million +5.3%13.2%20.4 $35.82 7/15/20217,620,000 shares $326.90 million -0.4%12.6%21.2 $42.90 6/30/20217,650,000 shares $338.82 million -4.0%12.6%21.8 $44.29 6/15/20217,970,000 shares $370.61 million -1.1%13.1%20.1 $46.50 5/28/20218,060,000 shares $342.55 million -1.0%13.3%18.6 $42.50 5/14/20218,140,000 shares $333.25 million +2.3%N/A17.3 $40.94 4/30/20217,960,000 shares $368.15 million -3.2%N/A16 $46.25 4/15/20218,220,000 shares $357.82 million -6.7%N/A16.7 $43.53 3/31/20218,810,000 shares $381.83 million +7.2%N/A17.3 $43.34 3/15/20218,220,000 shares $440.76 million -0.4%N/A15.7 $53.62 2/26/20218,250,000 shares $427.85 million +0.7%N/A11.2 $51.86 2/12/20218,190,000 shares $489.11 million -1.3%N/A11.2 $59.72 1/29/20218,300,000 shares $453.01 million +0.7%N/A11.5 $54.58 1/15/20218,240,000 shares $480.97 million +0.1%N/A11.9 $58.37 12/31/20208,230,000 shares $461.29 million -10.8%N/A12.3 $56.05 12/15/20209,230,000 shares $517.53 million +1.5%N/A14.8 $56.07 11/30/20209,090,000 shares $291.24 million -0.6%N/A19.9 $32.04 11/15/20209,140,000 shares $292.21 million -5.8%N/A30.3 $31.97 10/30/20209,700,000 shares $279.65 million +0.6%N/A35.5 $28.83 10/15/20209,640,000 shares $268.76 million +0.8%N/A34.6 $27.88 9/30/20209,560,000 shares $218.54 million +0.5%N/A32 $22.86 9/15/20209,510,000 shares $230.81 million +0.4%N/A25.9 $24.27 8/31/20209,470,000 shares $242.15 million -0.3%N/A23.1 $25.57 RCKT Short Interest - Frequently Asked Questions What is Rocket Pharmaceuticals' current short interest? Short interest is the volume of Rocket Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of July 31st, investors have sold 11,230,000 shares of RCKT short. 13.83% of Rocket Pharmaceuticals' shares are currently sold short. Learn More on Rocket Pharmaceuticals' current short interest. What is a good short interest ratio for Rocket Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RCKT shares currently have a short interest ratio of 2.0. Learn More on Rocket Pharmaceuticals's short interest ratio. Which institutional investors are shorting Rocket Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Rocket Pharmaceuticals: Nomura Holdings Inc., Group One Trading LLC, Jane Street Group LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Rocket Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.83% of Rocket Pharmaceuticals' floating shares are currently sold short. Is Rocket Pharmaceuticals' short interest increasing or decreasing? Rocket Pharmaceuticals saw a decline in short interest during the month of July. As of July 31st, there was short interest totaling 11,230,000 shares, a decline of 12.9% from the previous total of 12,900,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Rocket Pharmaceuticals' short interest compare to its competitors? 13.83% of Rocket Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Rocket Pharmaceuticals: Phibro Animal Health Corporation (5.04%), Xeris Biopharma Holdings, Inc. (12.06%), CureVac N.V. (0.78%), Enliven Therapeutics, Inc. (12.93%), Collegium Pharmaceutical, Inc. (13.98%), Intellia Therapeutics, Inc. (28.56%), Pharvaris N.V. (1.98%), Structure Therapeutics Inc. Sponsored ADR (13.14%), Tilray Brands, Inc. (17.02%), Arcus Biosciences, Inc. (13.81%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Rocket Pharmaceuticals stock? Short selling RCKT is an investing strategy that aims to generate trading profit from Rocket Pharmaceuticals as its price is falling. RCKT shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Rocket Pharmaceuticals? A short squeeze for Rocket Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RCKT, which in turn drives the price of the stock up even further. How often is Rocket Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RCKT, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies Phibro Animal Health Short Squeeze Xeris Biopharma Short Squeeze CureVac Short Squeeze Enliven Therapeutics Short Squeeze Collegium Pharmaceutical Short Squeeze Intellia Therapeutics Short Squeeze Pharvaris Short Squeeze Structure Therapeutics Short Squeeze Tilray Brands Short Squeeze Arcus Biosciences Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RCKT) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access